Recruiter Shortlist

Candidate Basket (2)

Review candidate cases selected for Phase 2 Study of Targeted Combination Therapy in EGFR-Mutated Advanced NSCLC. Prepare and dispatch in-app notifications of interest directly to patient portals on sites.eligara.ai.

← Add More Candidates

Selected Patient Candidates

2 cases selected
Candidate #PT-9481 Name Hidden
96% Match
Stage IV Non-Small Cell Lung Cancer (Adenocarcinoma)
62 yo Female • Cambridge, MA (4.2 miles from site) • ECOG 1
EGFR Exon 19 del (+) T790M (-) PD-L1 15% KRAS WT
Notification Sent
Candidate #PT-4109 Name Hidden
92% Match
Recurrent Stage IV NSCLC (Acinar Predominant)
58 yo Male • Newton, MA (8.5 miles from site) • ECOG 0
EGFR L858R (+) T790M (-) Exon 20 WT PD-L1 45%
✓ Patient Interested
Outreach Composer

Send Notification of Interest

This message will appear as an in-app notification inside the patient's sites.eligara.ai portal. The patient can review the trial opportunity and click "I'm Interested in Connecting".

🔒
Zero PHI Exposure: You will not see the patient's identity or contact details unless the patient reviews this invite and explicitly clicks "I'm Interested in Connecting".